DeepFacts charts pan-India expansion for AI remote patient monitoring platform proRITHM

In July 2026, DeepFacts Pvt. Ltd., the HealthTech company behind proRITHM, announced its expansion roadmap and how it plans to strengthen its presence across states like Andhra Pradesh, Karnataka, Tamil Nadu, and Odisha before expanding across India by early 2027. The company already has a presence in Telangana and is now preparing to enter the US market by late 2027 or early 2028 as it continues to scale its AI-enabled healthcare solutions.

Designed to support continuous patient monitoring, DeepFacts Pvt. Ltd. combines wearable technology with artificial intelligence to enable early health risk detection and remote clinical monitoring. The platform will allow healthcare providers to monitor vital health parameters in real time. As part of its technology development efforts. The company has already secured three granted patents, further reinforcing its focus on developing proprietary healthcare technologies.

DeepFacts Pvt. Ltd. has also received recognition through national programs and government-backed initiatives. The company was selected among the Top 4 AI-based Healthcare Technologies at the AI in Healthcare 2.0 International Conference, organized by Yashoda Hospitals and RICH. It was also the second runner-up in the AP MedTech Challenge, organized by the Government of Andhra Pradesh and RTIH, under the Remote Care and Telemedicine category.

The company is also recognized and supported by TIH, IIT Bombay, DRISHI CPS Foundation, IIT Indore, and GHRTBIF. With a growing intellectual property portfolio, expanding collaborations with healthcare providers, and a roadmap for domestic and international growth, DeepFacts Pvt. Ltd. aims to accelerate the adoption of proRITHM, its AI-powered remote patient monitoring platform, while contributing to healthcare accessibility and patient outcomes.

Impact on the Healthcare Market

Artificial intelligence (AI) is a technological revolution that is redefining modern medicine. From accelerating diagnoses to personalizing treatment plans, AI is poised to tackle some of healthcare's most pressing challenges. AI is poised to help solve healthcare’s greatest challenges, which are the growing need for serious or complex care, increased rates of chronic disease, a shortage of healthcare workers, and the explosion of data and technology tools.

AI technologies can now process and synthesize data far more quickly than humans. This allows clinicians and healthcare professionals to gain actionable, personalized, and predictive insights for individual patients. For instance, AI can analyze a patient's medical history, pathology reports, and imaging scans in minutes to identify patterns and recommend tailored treatments.

Integrating AI into clinical workflows can greatly help to enhance patient outcomes by detecting disease early and expediting drug discovery. AI's ability to analyze complex datasets allows for the identification of subtle indicators of disease, facilitating timely intervention. Additionally, AI-driven drug discovery processes can accelerate the development of new treatments, making them available to patients more quickly.

Impact on the AI In Healthcare Governance and Safety Market

The global AI in healthcare governance and safety market size was USD 2.40 billion in 2025 and is projected to increase from USD 2.96 billion in 2026 to approximately USD 19.65 billion by 2035, expanding at a CAGR of 23.40% from 2026 to 2035.

According to Precedence Research, market growth is attributed to the increasing adoption of AI-powered governance platforms for improving patient safety, operational transparency, and real-time healthcare risk management. Healthcare providers increasingly adopt governance platforms, explainable AI tools, and compliance monitoring systems across clinical environments. These technologies support hospitals' monitoring of algorithm behavior, identification of bias, patient data security, and regulatory compliance.

High spending on responsible AI infrastructure across hospitals and healthcare networks is estimated to support long-term expansion of governance and safety technologies worldwide. Healthcare enterprises are taking a managed approach to overseeing the use of AI in radiology, pathology, revenue cycle operations, and other workflows through a centralized governance structure. Healthcare organizations are also increasing their focus and investment in synthetic data platforms and privacy-preserving AI training environments to heighten compliance and maintain operational security.

Impact on the Generative AI In Healthcare Market

The global generative AI in healthcare market size is valued at USD 2.64 billion in 2025 and is predicted to increase from USD 3.57 billion in 2026 to approximately USD 48.23 billion by 2035, expanding at a CAGR of 33.71% from 2026 to 2035.

According to Precedence Research, the global generative AI in the healthcare market is being driven by several factors, including growing collaboration among the key players, technological advancements, and growing research and development activities.

The generative AI market in healthcare is driven by collaborative efforts between technology providers, healthcare institutions, and research organizations. These collaborations foster the exchange of knowledge, resources, and expertise, pushing the boundaries of generative AI applications in healthcare. Additionally, advancements in AI technologies, computational power, and data availability contribute to the growth and sophistication of generative AI solutions. Thus, this is expected to open opportunities for the growth of the market during the forecast period.

Expert Opinion

Vamsi Karatam, Founder & CEO, DeepFacts Pvt. Ltd., said,

“The future of healthcare lies in continuous, intelligent monitoring that enables timely interventions rather than reactive treatment. Our focus is to make clinically reliable remote monitoring accessible to healthcare providers across India while building globally relevant technology. The next phase of our expansion is centered on strengthening our presence in key Indian markets, deepening collaborations with healthcare partners, and preparing for international expansion.